Pro Medicus Limited Stock Current Ratio
| PMCUF Stock | USD 72.52 3.27 4.72% |
Pro Medicus Limited fundamentals help investors to digest information that contributes to Pro Medicus' financial success or failures. It also enables traders to predict the movement of Pro Pink Sheet. The fundamental analysis module provides a way to measure Pro Medicus' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pro Medicus pink sheet.
Pro |
Pro Medicus Limited Company Current Ratio Analysis
Pro Medicus' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Pro Medicus Current Ratio | 4.46 X |
Most of Pro Medicus' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pro Medicus Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Pro Medicus Limited has a Current Ratio of 4.46 times. This is 53.26% higher than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The current ratio for all United States stocks is 106.48% lower than that of the firm.
Pro Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pro Medicus' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Pro Medicus could also be used in its relative valuation, which is a method of valuing Pro Medicus by comparing valuation metrics of similar companies.Pro Medicus is currently under evaluation in current ratio category among related companies.
Pro Fundamentals
| Return On Equity | 0.48 | |||
| Return On Asset | 0.27 | |||
| Profit Margin | 0.47 % | |||
| Operating Margin | 0.66 % | |||
| Current Valuation | 4.1 B | |||
| Shares Outstanding | 104.43 M | |||
| Shares Owned By Insiders | 55.93 % | |||
| Shares Owned By Institutions | 11.91 % | |||
| Price To Earning | 220.99 X | |||
| Price To Book | 60.60 X | |||
| Price To Sales | 41.32 X | |||
| Revenue | 93.4 M | |||
| Gross Profit | 93.64 M | |||
| EBITDA | 69.64 M | |||
| Net Income | 44.44 M | |||
| Cash And Equivalents | 90.55 M | |||
| Cash Per Share | 0.87 X | |||
| Total Debt | 2.28 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 4.46 X | |||
| Book Value Per Share | 0.98 X | |||
| Cash Flow From Operations | 61.58 M | |||
| Earnings Per Share | 0.29 X | |||
| Number Of Employees | 16 | |||
| Beta | 0.57 | |||
| Market Capitalization | 4.78 B | |||
| Total Asset | 157.05 M | |||
| Retained Earnings | 25 M | |||
| Working Capital | 17 M | |||
| Current Asset | 25 M | |||
| Current Liabilities | 8 M | |||
| Annual Yield | 0 % | |||
| Five Year Return | 0.92 % | |||
| Net Asset | 157.05 M | |||
| Last Dividend Paid | 0.22 |
About Pro Medicus Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pro Medicus Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pro Medicus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pro Medicus Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pro Medicus in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pro Medicus' short interest history, or implied volatility extrapolated from Pro Medicus options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pro Medicus Limited using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pro Medicus Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Pro Pink Sheet analysis
When running Pro Medicus' price analysis, check to measure Pro Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Medicus is operating at the current time. Most of Pro Medicus' value examination focuses on studying past and present price action to predict the probability of Pro Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Medicus' price. Additionally, you may evaluate how the addition of Pro Medicus to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |